Where does the 24% mold susceptibility figure come from?

The 24% figure comes from Dr. Shoemaker's comparison of HLA-DR haplotype frequencies in his patient population to international HLA registry data. He estimates that approximately one-quarter of the normal population carries haplotypes associated with impaired biotoxin clearance. This figure has not been independently replicated in a large-scale population genetics study specifically examining mold illness susceptibility.

Should I get an HLA-DR genetic test for mold susceptibility?

The clinical utility of HLA-DR testing for mold susceptibility is debated. A positive result (susceptible haplotype) cannot be acted on directly — the primary intervention is still environmental: identifying and remediating mold in your home or workplace. A professional mold inspection is the most actionable first step regardless of genetic susceptibility.

Does having the HLA-DR susceptibility gene mean I will get sick from mold?

According to Shoemaker's theory, carrying susceptible HLA-DR haplotypes increases risk but does not guarantee illness. Many people with susceptible haplotypes live without significant mold illness. The degree of mold exposure, species of mold, duration of exposure, and overall health status all play roles. Environmental remediation is beneficial regardless of genetic status.

Mold Genetics Research • 2026

HLA-DR Mold Susceptibility: What the 24% Statistic Actually Means

Q: What is the HLA-DR gene and why does it matter for mold?

HLA-DR is a gene that encodes a protein involved in immune antigen presentation. Dr. Ritchie Shoemaker's CIRS (Chronic Inflammatory Response Syndrome) theory proposes that approximately 24% of the population carries HLA-DR/DQ haplotypes that prevent the immune system from properly tagging and removing mycotoxins and other biotoxins, causing them to recirculate and trigger chronic inflammation.

Q: Has the HLA-DR mold susceptibility claim been independently validated?

No large-scale independent replication study has confirmed the 24% CIRS susceptibility figure in mold-specific illness. A 2024 PubMed case study (PMID 38198040) found HLA gene variations affecting mycotoxin toxicity in 4 patients, providing limited supporting data. The mainstream immunology and allergy communities have not formally endorsed the CIRS/biotoxin model.

~24% of the population estimated to carry HLA-DR/DQ haplotypes associated with impaired biotoxin clearance — per Dr. Shoemaker's comparison to international HLA registries. Independent population-scale replication is still lacking.

The "24% of people can't detox mold" claim is cited on virtually every CIRS webpage. Here is where it actually comes from, what the limitations are, and what mainstream immunology says about it.

✆ Mold Inspection: (332) 220-0303 Read the Analysis

HLA-DR Mold Genetic Susceptibility Research

Key Facts

What the Evidence Shows

~24%estimated genetic susceptibility per Shoemaker's research

Derived from comparing patient HLA haplotype frequencies to international registry data — not from a controlled trial of mold-exposed vs non-exposed populations.

0large-scale independent replication studies of the 24% figure

No independent research team has run a population-scale study validating this specific percentage for mold-illness susceptibility.

2024year of most recent HLA-mold study (case series)

A 2024 PubMed paper (PMID 38198040) found HLA gene variations affecting mycotoxin toxicity in 4 patients — providing limited supporting evidence.

Not Endorsedby AAAAI or mainstream allergy/immunology

The American Academy of Allergy, Asthma & Immunology has not formally endorsed the CIRS/biotoxin illness model as a recognized clinical syndrome.

Background

What HLA-DR Is and What Shoemaker Claims

HLA-DR (Human Leukocyte Antigen, DR subtype) is a gene that encodes proteins on immune cells critical for antigen presentation — the process by which the immune system identifies and tags foreign substances for removal. Different HLA haplotypes vary in their ability to "present" different types of antigens.

The CIRS Theory

Dr. Ritchie Shoemaker, a pioneer of the Chronic Inflammatory Response Syndrome (CIRS) model, proposed that approximately 24% of the population carries HLA-DR/DQ haplotypes that cannot effectively present mycotoxins (and other biotoxins) to the immune system for tagging and removal. In these individuals, he theorizes that mycotoxins recirculate indefinitely, triggering chronic, multi-system inflammation.

Per his published protocol: "In normal populations compared to international registries of gene frequencies of HLA-DR, the frequency of mold illness-susceptible patients approximates 24% of the normally distributed population. Almost a quarter of the normal population is genetically susceptible to chronic mold illness."

Where the 24% Figure Comes From

The figure is not from a controlled clinical trial. It derives from Shoemaker comparing the HLA haplotype distribution in his CIRS patient population to published international HLA frequency databases. The specific haplotypes he identifies as "susceptible" appear in approximately 24% of the general population in those registries.

HLA-DR Population Genetics Mold Susceptibility Data

Validation Status

What Independent Research Has Found

Research / Source	Finding	Independent?	Year
Shoemaker & House — original CIRS HLA-DR publications	~24% of population carries susceptible haplotypes; these patients cannot clear biotoxins normally	No — author's own research	2003–2010
PubMed PMID 38198040 — HLA gene variations and mycotoxin toxicity	Case series of 4 patients showing HLA variation affected mycotoxin toxicity	Partial — independent authors	2024
AAAAI (American Academy of Allergy, Asthma & Immunology)	Has not formally recognized CIRS/biotoxin illness as a validated clinical syndrome	Yes — consensus body	Current
HyperCharge Health — Forensic Audit of Shoemaker Protocol	Identifies methodological concerns with the biotoxin pathway model and supporting studies	Yes — independent analysis	Recent
International HLA Registries (gnomAD, 1000 Genomes)	HLA-DR allele frequencies vary significantly by population; overall diversity supports the existence of multiple haplotypes including those Shoemaker identifies	Yes — population databases	Ongoing

Sources: survivingmold.com; PubMed 38198040; hyperchargehealth.com; kashilab.com HLA-DR Report; avoidingmold.com genetic testing guide.

Clinical Implications

What This Means If You Test Positive for Susceptible HLA-DR

Several commercial labs (Life Extension, Kashi Lab, others) offer HLA-DR mold susceptibility testing. If your results show a "susceptible" haplotype, here is what that does — and doesn't — tell you:

What a Positive HLA-DR Result Means

According to the Shoemaker model: your immune system may have difficulty clearing mycotoxins, making prolonged mold exposure more likely to cause or perpetuate chronic symptoms. It may explain why you feel worse than others in the same moldy environment.

What It Doesn't Tell You

A susceptible HLA-DR result cannot: (1) confirm you are currently ill from mold, (2) identify which mold species or building is responsible, (3) replace an environmental inspection of your home, or (4) guide remediation decisions. Many people with susceptible haplotypes live without significant mold illness when they live in dry, well-maintained buildings.

The Most Actionable Step Regardless of Genetics

Whether or not you carry susceptible HLA-DR variants, the primary intervention for mold illness is environmental. An ACAC-certified inspector or CIH can assess your home for water damage and elevated spore counts. See our guide on mold inspector credentials to find a qualified professional, and understand indoor spore count guidelines to interpret any test results.

Frequently Asked Questions

HLA-DR Mold Susceptibility: FAQs

What is the HLA-DR mold susceptibility gene?

HLA-DR is a gene that encodes immune proteins responsible for antigen presentation. Dr. Shoemaker's CIRS theory proposes that ~24% of people carry HLA-DR/DQ variants that impair the immune system's ability to tag and clear mycotoxins, causing them to recirculate and produce chronic inflammation.

Is the 24% mold susceptibility figure proven?

The figure has not been independently validated in a controlled, large-scale clinical study. It derives from Shoemaker comparing HLA haplotype frequencies in his patient population to international registry data — not from a randomized study of mold-exposed vs control populations. A 2024 PubMed case study provides limited supportive data, but mainstream immunology has not formally confirmed the CIRS model.

Should I get an HLA-DR test if I think I have mold illness?

The clinical utility of HLA-DR testing for mold illness is debated. A professional environmental inspection of your home is a more actionable first step — it identifies whether you have a mold exposure source that can be remediated. HLA testing may inform treatment approach but cannot tell you whether mold is in your home. Call (332) 220-0303 for guidance on environmental testing.

Does the AAAAI recognize CIRS as a medical condition?

The American Academy of Allergy, Asthma & Immunology and mainstream US medical organizations have not formally recognized CIRS (Chronic Inflammatory Response Syndrome) as a validated clinical diagnosis. The CIRS model is primarily practiced by practitioners trained in the Shoemaker protocol and integrative/functional medicine physicians.

Can I have mold illness without the HLA-DR susceptibility gene?

Yes. Even without the CIRS-associated HLA haplotypes, individuals can experience mold-related illness through allergic reactions, direct mycotoxin toxicity, infections (especially in immunocompromised people), and respiratory irritation. The HLA-DR susceptibility model addresses only one proposed mechanism of mold-related illness.

Related Research

More Evidence-Based Mold Health Guides

Sources

Citations & References

Dr. Shoemaker — 12-Step CIRS Protocol: https://www.survivingmold.com/docs/12_STEP_SHOEMAKER_PROTOCOL_FOR_CIRS.PDF
PubMed 38198040 — HLA gene variations and mycotoxin toxicity (2024): https://pubmed.ncbi.nlm.nih.gov/38198040/
Kashi Lab — HLA-DR/DQ Mold Sensitivity Report: https://kashilab.com/wp-content/uploads/2024/06/Mold-Sensitivity-Report-1.pdf
HyperCharge Health — Forensic Audit of Shoemaker Protocol: https://www.hyperchargehealth.com/blog/the-shoemaker-protocol-a-forensic-audit-of-the-standard-of-care-for-biotoxin-illness
MoldCo.com — Mold Illness Testing Guide (2025): https://www.moldco.com/blog/mold-illness-testing
Life Extension — HLA-DR Mold Genetic Test: https://www.lifeextension.com/lab-testing/itemlc100087/hla-dr-mold-genetic-test